the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
Last Updated on April 30, 2016 by Joseph Gut – thasso April 29, 2016 – The American Food and Drug Administration (FDA) has approved Pimavanserin (Nuplazid), the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s …
Last Updated on April 14, 2016 by Joseph Gut – thasso April 14, 2016 – This post is based on materials provided by U.S. Centers for Disease Control and Prevention (CDC), which have been discussed in ScienceDaily, on 13 April 2016, and were published in …
Zika virus causes microcephaly and other birth defects Read more »
Last Updated on April 12, 2016 by Joseph Gut – thasso April 12, 2016 – The American Food and Drug Administration (FDA) just approved Venetoclax (Venclexta) for the treatment of patients with chronic lymphocytic leukemia (CLL) who have a chromosomal …
Last Updated on April 6, 2016 by Joseph Gut – thasso April o5, 2016 – There have been indications that a heightened risk of heart failure may be associated with diabetes medications containing the pharmacologically active ingredients saxagliptin or alogliptin. …
Last Updated on April 3, 2016 by Joseph Gut – thasso April 02, 2016 – The European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union (EU) for a new gene therapy for the treatment of patients with adenosine-deaminase-deficient severe combined …
Last Updated on April 2, 2016 by Joseph Gut – thasso March 31, 2016 – The American Food and Drug Administration (FDA) just approved Defibrotide sodium (Defitelio) to treat adults and children who develop hepatic veno-occlusive disease (VOD) with additional kidney or lung abnormalities after …